U.S. Stem Cell, Inc. (USRM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
At close: Oct 28, 2026
U.S. Stem Cell Market Cap
U.S. Stem Cell has a market cap or net worth of $66.15 thousand as of November 6, 2026. It is the 51,305th most valuable company in the world and the 7,338th biggest in the United States.
Market Cap
66.15K
Enterprise Value
n/a
Revenue
82.05K
Global Rank
Country Rank
#7,338 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 19, 2008, U.S. Stem Cell's market cap has decreased from 66.74M to 66.15K, a decrease of -99.90%. That is a compound annual growth rate of -30.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 66.15K | 9,892.60% |
| Dec 31, 2025 | 662.00 | -99.00% |
| Dec 31, 2024 | 66.15K | 9,892.60% |
| Dec 26, 2023 | 662.00 | -99.98% |
| Dec 30, 2022 | 3.05M | 0.79% |
| Dec 31, 2021 | 3.02M | -43.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Innovation Pharmaceuticals | 105.75K |
| Aditxt | 99.80K |
| Ocean Biomedical | 92.95K |
| PaxMedica | 88.39K |
| Vincerx Pharma | 78.51K |
| Affymax | 59.59K |